系统生物学是系统论与生物学的结合。它包括基因组学、蛋白质组学、转录组学和代谢组学等。利用系统论的思维方法研究生命现象，从多学科、多视角认识中医证候和中医药疗效机制，为中医研究提供了重要的方法学基础和技术条件；系统生物学与中医学系统观和整体观念的核心思想不谋而合。因此，将系统生物学作为非酒精性脂肪性肝病（NAFLD）的现代中医药研究平台和支点，必将加速中医药防治NAFLD的现代化研究，也为中医药研究NAFLD 提供新思路和新途径。

Systems biology, which includes genomics, proteomics, transcriptomics and metabolomics, is an integration of system theory and biology. It studies the life phenomena with thinking method of systems theory. And it provides an important methodological basis and technical conditions for recognizing syndrome of traditional Chinese medicine (TCM) and mechanism of therapeutic effect from multiple disciplines and perspectives. Systems biology is similar to the core idea of TCM system and holism concept. Therefore, systems biology can be used as a platform and pivot of non-alcoholic fatty liver disease (NAFLD) in modern TCM study. Systems biology will accelerate the modernization research of TCM in the prevention and treatment of NAFLD. It will also provide new ideas and methods for TCM study on NAFLD.

国家自然科学基金委面上项目（81173404）：基于肝脂肪代谢环节的中药组分“BZL”复方防治非酒精性脂肪肝作用机理研究，负责人：胡义扬；国家自然科学基金委面上项目（81384031）：基于GLP-1受体相关信号通路的京尼平苷与绿原酸组合治疗非酒精性脂肪肝效应机制研究，负责人：冯琴；上海自然科学基金委项目（13ZR1442600）：基于GLP-1受体相关信号通路的中药组分复方GC 方防治非酒精性脂肪肝的机理研究，负责人：冯琴。